Upgrade to SI Premium - Free Trial

Transcat, Inc. (TRNS) Tops Q1 EPS by 14c

July 21, 2020 4:21 PM

Transcat, Inc. (NASDAQ: TRNS) reported Q1 EPS of $0.11, $0.14 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $38.9 million versus the consensus estimate of $39.39 million.

“We are extremely proud of our organization and the invaluable contributions our people made during these difficult times. Our staff at our 42 labs have worked tirelessly to remain open and meet the demands of our customers, particularly those in the Life Sciences sector,” commented Lee D. Rudow, President and CEO. “Our first quarter results are a testament to the value and effective execution of our strategy. Our commitment to technology and process improvements positively impacted our results as increased productivity drove higher Service segment gross margins. We believe the improvements are sustainable and we expect to see additional traction and margin enhancement as we move forward.”

Mr. Rudow added, “The 20% decline in Distribution sales was expected and was the direct result of the impact of the COVID-19 pandemic on customer demand throughout the quarter. Nonetheless, the contribution from the Service business combined with company-wide cost saving measures, which we implemented early on in the pandemic to protect the financial strength and liquidity of the Company, and which continued in our first quarter, resulted in operating income of $1.0 million for the first quarter. This exceeded our expectation of operating income being in the break-even range that we had forecast in May 2020 when we released fiscal year-end results.”

For earnings history and earnings-related data on Transcat, Inc. (TRNS) click here.

Categories

Corporate News Earnings Management Comments

Next Articles